140 related articles for article (PubMed ID: 4021726)
21. In vitro down-regulation predicts agonist efficacy at central muscarinic cholinergic receptors.
Stoll L; Müller WE
Biochem Pharmacol; 1991 Jun; 41(12):1963-6. PubMed ID: 2039547
[TBL] [Abstract][Full Text] [Related]
22. Short-term regulation of muscarinic acetylcholine receptor binding in cultured nerve cells.
Feigenbaum P; El-Fakahany EE
Res Commun Chem Pathol Pharmacol; 1984 Mar; 43(3):519-22. PubMed ID: 6718813
[TBL] [Abstract][Full Text] [Related]
23. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
[TBL] [Abstract][Full Text] [Related]
24. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
[TBL] [Abstract][Full Text] [Related]
25. Autoradiographic localization of muscarinic cholinergic receptors in visual areas of cat brain: variations in sensitivity of N-[3H]methylscopolamine binding sites to carbachol and pirenzepine.
Cymerman U; Palacios JM; Cortés R; Skangiel-Kramska J
Neurosci Lett; 1987 Oct; 81(1-2):13-8. PubMed ID: 3696462
[TBL] [Abstract][Full Text] [Related]
26. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
Waelbroeck M; Gillard M; Robberecht P; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):91-9. PubMed ID: 3600616
[TBL] [Abstract][Full Text] [Related]
27. Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
Rinner I; Porta S; Schauenstein K
Endocrinol Exp; 1990 Mar; 24(1-2):125-32. PubMed ID: 2361455
[TBL] [Abstract][Full Text] [Related]
28. Influence of thiol groups, calcium, and glucose metabolism on cholinergic-induced insulin release and on methylscopolamine binding to muscarinic receptors in pancreatic islets of the rat.
Grill V; Fåk K
Acta Endocrinol (Copenh); 1985 Jul; 109(3):355-60. PubMed ID: 2411095
[TBL] [Abstract][Full Text] [Related]
29. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
Waelbroeck M; Gillard M; Robberecht P; Christophe J
Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
[TBL] [Abstract][Full Text] [Related]
30. Determination of the association and dissociation rate constants of muscarinic antagonists on rat pancreas: rank order of potency varies with time.
Waelbroeck M; Camus J; Christophe J
Mol Pharmacol; 1989 Sep; 36(3):405-11. PubMed ID: 2779525
[TBL] [Abstract][Full Text] [Related]
31. Affinity changes in muscarinic acetylcholine receptors in the rat brain following acute immobilization stress: an autoradiographic study.
González AM; Pazos A
Eur J Pharmacol; 1992 Apr; 214(2-3):261-8. PubMed ID: 1516642
[TBL] [Abstract][Full Text] [Related]
32. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
Baker SP; Posner P
Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of muscarinic and nicotinic receptors by cholinergic stimulation in cultured avian retina cells.
Siman RG; Klein WL
Brain Res; 1983 Feb; 262(1):99-108. PubMed ID: 6831232
[TBL] [Abstract][Full Text] [Related]
34. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
35. Protein toxins that bind to muscarinic acetylcholine receptors.
Karlsson E; Jolkkonen M; Satyapan N; Adem A; Kumlin E; Hellman U; Wernstedt C
Ann N Y Acad Sci; 1994 Mar; 710():153-61. PubMed ID: 8154745
[No Abstract] [Full Text] [Related]
36. Increased muscarinic responsiveness and decreased muscarinic receptor content in ileal smooth muscle in diabetes.
Carrier GO; Aronstam RS
J Pharmacol Exp Ther; 1990 Aug; 254(2):445-9. PubMed ID: 2384882
[TBL] [Abstract][Full Text] [Related]
37. Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics.
Anthony BL; Dennison RL; Aronstam RS
Neurosci Lett; 1989 Apr; 99(1-2):191-6. PubMed ID: 2501717
[TBL] [Abstract][Full Text] [Related]
38. Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state.
Narayanan TK; Aronstam RS
Neurochem Res; 1986 Oct; 11(10):1397-406. PubMed ID: 3785535
[TBL] [Abstract][Full Text] [Related]
39. Long-term carbachol treatment-induced down-regulation of muscarinic M2-receptors but not m2 receptor mRNA in a human lung cell line.
Haddad EB; Rousell J; Mak JC; Barnes PJ
Br J Pharmacol; 1995 Oct; 116(3):2027-32. PubMed ID: 8640341
[TBL] [Abstract][Full Text] [Related]
40. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats.
Ehlert FJ; Delen FM
Mol Pharmacol; 1990 Jul; 38(1):143-7. PubMed ID: 2370852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
